Aflac (AFL) Stock Forecast & Price Target

Q: What analysts cover Aflac?

Aflac has been rated by research analysts at Barclays , Jefferies Financial Group , JPMorgan Chase & Co. , Keefe, Bruyette & Woods , Mizuho , Morgan Stanley , Piper Sandler , TD Cowen , UBS Group , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$125.61 +0.01 (+0.01%)

Closing price 07/24/2026 03:59 PM Eastern

Extended Trading

$125.53 -0.08 (-0.06%)

As of 07/24/2026 07:34 PM Eastern

Compare

Aflac - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 13 Analyst Ratings

Sell
2

Hold
7

Buy
4

Based on 13 Wall Street analysts who have issued ratings for Aflac in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 2 have given a sell rating, 7 have given a hold rating, 2 have given a buy rating, and 2 have given a strong buy rating for AFL.

Consensus Price Target

$116.17
-7.52% Downside

According to the 13 analysts' twelve-month price targets for Aflac, the average price target is $116.17. The highest price target for AFL is $130.00, while the lowest price target for AFL is $98.00. The average price target represents a forecasted downside of -7.52% from the current price of $125.61.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for AFL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Aflac and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AFL Analyst Ratings Over Time

Type	Current Forecast 7/27/25 to 7/27/26	1 Month Ago 6/27/25 to 6/27/26	3 Months Ago 4/28/25 to 4/28/26	1 Year Ago 7/27/24 to 7/27/25
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	3 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$116.17	$112.27	$111.82	$108.15
Forecasted Upside	-7.52% Downside	-6.47% Downside	-3.77% Downside	4.60% Upside
Consensus Rating	Hold	Hold	Hold	Hold

AFL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AFL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Aflac Stock vs. The Competition

Type	Aflac	Finance Companies	Broader Market
Consensus Rating Score	2.31	2.32	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-7.52% Downside	30.73% Upside	14.30% Upside
News Sentiment Rating	Positive News See Recent AFL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/23/2026	Weiss Ratings 5 of 5 stars		Upgrade	Buy (B+) ➝ Buy (A-)
7/22/2026	TD Cowen 3 of 5 stars	Andrew Kligerman Not Rated	Reiterated Rating	Hold	$101.00 ➝ $110.00	-11.32%
7/21/2026	JPMorgan Chase & Co. 3 of 5 stars	Pablo Singzon Not Rated	Boost Target	Neutral	$108.00 ➝ $117.00	-4.82%
7/13/2026	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Krueger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Market Perform	$115.00 ➝ $120.00	-1.62%
7/10/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suneet Kamath Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Hold	$100.00 ➝ $108.00	-11.39%
7/9/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yaron Kinar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$112.00	-7.28%
7/9/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wesley Carmichael Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$111.00 ➝ $120.00	-1.49%
7/8/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Meredith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral	$114.00 ➝ $124.00	+2.44%
7/7/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Scott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Underweight	$99.00 ➝ $98.00	-18.64%
5/26/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Newsome Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$125.00 ➝ $130.00	+10.38%
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself
5/21/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nigel Dally Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$120.00 ➝ $125.00	+6.24%
4/9/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Strong-Buy
12/30/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wilma Burdis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$110.00 ➝ $119.00	+8.20%
1/23/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jack Matten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Market Perform	$111.00	+6.46%
11/1/2024	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$100.00 ➝ $105.00	-0.72%
10/10/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$115.00 ➝ $124.00	+11.27%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 04:42 AM ET.

Should I Buy Aflac Stock? AFL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, July 22, 2026. Please send any questions or comments about these Aflac pros and cons to contact@marketbeat.com.

Aflac
Bull Case

Here are some ways that investors could benefit from investing in Aflac Incorporated:

The current stock price is around $118, which reflects a stable valuation in the insurance sector.
Aflac Incorporated has a consistent dividend payout, recently announcing a quarterly dividend of $0.61, translating to an annualized dividend of $2.44 and a yield of 2.0%. This can provide a reliable income stream for investors.
The company maintains a low dividend payout ratio of 27.70%, indicating that it retains a significant portion of its earnings for growth and stability, which can be attractive for long-term investors.
Aflac Incorporated has a strong market presence in supplemental insurance, offering products that help policyholders manage out-of-pocket healthcare expenses, which is increasingly important in today's healthcare landscape.
Recent insider transactions show that major shareholders are actively managing their stakes, with a notable sale of shares under a pre-arranged trading plan, suggesting confidence in the company's future performance.

Aflac
Bear Case

Investors should be bearish about investing in Aflac Incorporated for these reasons:

Insider sales have totaled 744,916 shares worth over $87 million in the last quarter, which may raise concerns about the confidence of insiders in the company's future prospects.
Only 0.80% of the company's stock is owned by corporate insiders, which could indicate a lack of alignment between management and shareholder interests.
The insurance market can be highly competitive and subject to regulatory changes, which may impact Aflac's profitability and growth potential.
While the dividend yield is attractive, it is essential to consider that a low payout ratio may also mean that the company is not returning as much capital to shareholders compared to its earnings.
Market fluctuations and economic uncertainties can affect the demand for supplemental insurance products, potentially impacting Aflac's revenue streams.

AFL Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Aflac is $116.17, with a high forecast of $130.00 and a low forecast of $98.00.

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aflac in the last twelve months. There are currently 2 sell ratings, 7 hold ratings, 2 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AFL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFL, but not buy additional shares or sell existing shares.

According to analysts, Aflac's stock has a predicted downside of -7.52% based on their 12-month stock forecasts.

Over the previous 90 days, Aflac's stock had 3 upgrades and 3 downgrades by analysts.

Aflac has been rated by research analysts at Barclays, Jefferies Financial Group, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Mizuho, Morgan Stanley, Piper Sandler, TD Cowen, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Aflac less than other "finance" companies. The consensus rating score for Aflac is 2.31 while the average consensus rating score for "finance" companies is 2.32. Learn more on how AFL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Aflac Recommendations

This page (NYSE:AFL) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aflac (AFL) Stock Forecast & Price Target